Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

The latest news for pharma industry insiders.

Pharma Pulse 12/2/24: Addressing the Health Literacy Roadblock in Patient Recruitment & more

The transaction reaffirms the CDMO’s interest in growth on a global scale. 

Adragos Pharma Acquires Baccinex, Growing Sterile Manufacturing Services  

Pharma Pulse 11/29/24: The Advantages and Disadvantages of Using Compounded Medications & more

Pharma Pulse 11/28/24: Solving Clinical Technology Challenges with Integration & more

Podcasts

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

Nov. 27 is Here: What Does That Mean for DSCSA?

The proposal aims to reduce out-of-pocket costs for a number of weight loss medications by 95%.

Biden-Harris Administration Proposes Expansion to Medicare and Medicaid to Include Weight Loss Medications

Videos

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chase Feiger, MD, co-founder, Ostro, discusses the value of AI technology when it comes to tackling digital commercialization challenges.

AI’s Role in Personalizing Life Sciences Digital Experiences

Pharma Pulse 11/27/24: Practical Gains for Pharma AI Use, Key Trends in the Evolution of PBMs & more

Why well-organized documentation is critical at every stage of the process.

Technically Speaking: Quality Documentation is One of the Best Ways to Boost Performance

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, offers advice for effectively being able to adjust plans.

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right